Pak K, Kim S-J, Kim IJ (2018) Obesity and Brain Positron Emission Tomography. Nucl Med Mol Imaging 52:16–23

Article  PubMed  Google Scholar 

Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB (2019) Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity 27:7–9

Article  PubMed  Google Scholar 

van Galen KA, ter Horst KW, Booij J, la Fleur SE, Serlie MJ (2018) The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metabolism 85:325–339

Article  PubMed  Google Scholar 

Stanfill AG, Conley Y, Cashion A, Thompson C, Homayouni R, Cowan P, Hathaway D (2015) Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity. Biol Res Nurs 17:413–421

Article  CAS  PubMed  Google Scholar 

Galen KA, Horst KW, Serlie MJ (2021) Serotonin, food intake, and obesity. Obes Rev 22:1–13

Google Scholar 

Rossi MA, Stuber GD (2018) Overlapping Brain Circuits for Homeostatic and Hedonic Feeding. Cell Metab 27:42–56

Article  CAS  PubMed  Google Scholar 

Wang G-J, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusll N, Fowler JS (2001) Brain dopamine and obesity. The Lancet 357:354–357

Article  CAS  Google Scholar 

Dunn JP, Abumrad NN, Patterson BW, Kessler RM, Tamboli RA (2019) Brief communication: β-cell function influences dopamine receptor availability. PLoS ONE 14:e0212738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farr OM, Li CR, Mantzoros CS (2016) Central nervous system regulation of eating: Insights from human brain imaging. Metabolism 65:699–713

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janssen LK, Horstmann A (2022) Molecular Imaging of Central Dopamine in Obesity: A Qualitative Review across Substrates and Radiotracers. Brain Sci 12:486

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez Vicchi F, Luque GM, Brie B, Nogueira JP, Garcia Tornadu I, Becu-Villalobos D (2016) Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacol Res 109:74–80

Article  CAS  PubMed  Google Scholar 

Poulin M-J, Chaput J-P, Simard V et al (2007) Management of Antipsychotic-Induced Weight Gain: Prospective Naturalistic Study of the Effectiveness of a Supervised Exercise Programme. Aust N Z J Psychiatry 41:980–989

Article  PubMed  Google Scholar 

Wang G-J, Volkow ND, Fowler JS (2002) The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6:601–609

Article  CAS  PubMed  Google Scholar 

Baik J-H (2013) Dopamine signaling in food addiction: role of dopamine D2 receptors. BMB Rep 46:519–526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong DF (2002) In Vivo Imaging of D2 Dopamine Receptors in Schizophrenia. Arch Gen Psychiatry 59:31

Article  CAS  PubMed  Google Scholar 

Innis RB, Cunningham VJ, Delforge J et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539

Article  CAS  PubMed  Google Scholar 

Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, Salminen P, Nuutila P, Nummenmaa L (2015) Obesity Is Associated with Decreased -Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain. J Neurosci 35:3959–3965

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ribeiro G, Maia A, Cotovio G, Oliveira FPM, Costa DC, Oliveira-Maia AJ (2023) Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis. Sci Rep 13:4959

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pak K, Nummenmaa L (2023) Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta-analyses. Hum Brain Mapp 44:6552–6560

Article  PubMed  PubMed Central  Google Scholar 

Wang G-J, Tomasi D, Convit A, Logan J, Wong CT, Shumay E, Fowler JS, Volkow ND (2014) BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake. PLoS ONE 9:e101585

Article  PubMed  PubMed Central  Google Scholar 

Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD (2014) Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry 19:1078–1084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Zald DH (2016) Associations between dopamine D2 receptor availability and BMI depend on age. Neuroimage 138:176–183

Article  CAS  PubMed  Google Scholar 

Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T (2015) Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS ONE 10:e0133621

Article  PubMed  PubMed Central  Google Scholar 

Eisenstein SA, Antenor-Dorsey JAV, Gredysa DM et al (2013) A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[11C]methyl)benperidol. Synapse 67:748–756

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Weijer BA, Van De Giessen E, Van Amelsvoort TA, Boot E, Braak B, Janssen IM, Van De Laar A, Fliers E, Serlie MJ, Booij J (2011) Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res 1(1):37. https://doi.org/10.1186/2191-219X-1-37

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Zwaal EM, de Weijer BA, van de Giessen EM et al (2016) Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss. Eur Neuropsychopharmacol 26:1190–1200

Article  PubMed  Google Scholar 

van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J (2014) Dopamine D 2/3 receptor availability and amphetamine-induced dopamine release in obesity. J Psychopharmacol 28:866–873

Article  PubMed  Google Scholar 

Haltia LT, Rinne JO, Helin S, Parkkola R, Någren K, Kaasinen V (2008) Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse 62:682–688

Article  CAS  PubMed  Google Scholar 

Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H, Kumar A, Brasic J, Wong DF (2010) Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery. Obes Surg 20:369–374

Article  PubMed  Google Scholar 

Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Någren K, Kaasinen V (2007) Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 61:748–756

Article  CAS  PubMed  Google Scholar 

Caravaggio F, Raitsin S, Gerretsen P, Nakajima S, Wilson A, Graff-Guerrero A (2015) Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index. Biol Psychiat 77:196–202

Article  CAS  PubMed